IL-1β receptor antagonist (IL-1Ra) combined with an autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation of osteoarthritis in rats and humans. Here, BECN1 is linked to osteoarthritis.